Dems pressure Biden to share Moderna vaccine tech

A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Moderna won’t enforce COVID-19 patents

12 October 2020 Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over.

Big Pharma

Oxfam says Moderna hid vaccine dispute from investors

23 December 2021 Oxfam America has filed a complaint with the US Securities and Exchange Commission (SEC) claiming that Moderna failed to inform investors that it was in a dispute with the National Institutes of Health over a COVID–19 vaccine patent.

Americas

Warren calls for government to seize Pfizer patents

22 February 2022 US Senator Elizabeth Warren has urged the Department of Health and Human Services (HHS) to seize control of patents covering Pfizer’s prostate cancer drug Xtandi (enzalutamide).

More on this story

Big Pharma

Moderna won’t enforce COVID-19 patents

Big Pharma

Oxfam says Moderna hid vaccine dispute from investors

Americas

Warren calls for government to seize Pfizer patents

22 February 2022 US Senator Elizabeth Warren has urged the Department of Health and Human Services (HHS) to seize control of patents covering Pfizer’s prostate cancer drug Xtandi (enzalutamide).

More on this story

Big Pharma

Moderna won’t enforce COVID-19 patents

Big Pharma

Oxfam says Moderna hid vaccine dispute from investors

Americas

Warren calls for government to seize Pfizer patents

22 February 2022 US Senator Elizabeth Warren has urged the Department of Health and Human Services (HHS) to seize control of patents covering Pfizer’s prostate cancer drug Xtandi (enzalutamide).